Plasmid DNA Platform Supports Early Phase Advanced Therapies
Summary: Plasmid DNA has proven to be a critical starting material for advanced therapeutics including cell, gene, and mRNA therapies. In this executive summary, discover how a platform process for the manufacturing of plasmid DNA is helpful for all stages, from screening candidates in preclinical studies to large-scale production for late-stage and commercial needs.